Back to Search
Start Over
RETROSPECTIVE REAL-WORLD OUTCOMES FOR ALK-REARRANGED LUNG CANCER PATIENTS RECEIVING ALK-RECEPTOR TYROSINE KINASE INHIBITORS
- Source :
- JTO Clinical and Research Reports; 20210101, Issue: Preprints
- Publication Year :
- 2021
-
Abstract
- This study explored the use, safety and efficacy of initial use of an ALK-inhibiting targeted therapy (ALK-TKI) in ALK-rearranged NSCLC patients in a population-based, real-world clinical population within the province of Alberta, Canada.
Details
- Language :
- English
- ISSN :
- 26663643
- Issue :
- Preprints
- Database :
- Supplemental Index
- Journal :
- JTO Clinical and Research Reports
- Publication Type :
- Periodical
- Accession number :
- ejs55460041
- Full Text :
- https://doi.org/10.1016/j.jtocrr.2021.100157